Side-by-side comparison of AI visibility scores, market position, and capabilities
T-Mobile US Inc., 140M subscribers Sept 2025 (#2 US carrier), Q4 2024: 903K postpaid phone net adds (industry leader), Q2 2025: $17.4B service revenue (+6%), $3.2B net income (+10%), $2.84 EPS (+14%), 5G: 98% Americans covered, 300M+ high-capacity 5G, 2.5 GHz spectrum from Sprint merger, $8B run-rate synergies, targeting 12M 5G broadband by 2028
T-Mobile is a major wireless carrier operating nationwide networks providing mobile phone service, smartphones, data plans, and home internet across the United States. The company targets value-conscious consumers and families seeking unlimited data plans, competitive pricing, and customer-friendly policies. T-Mobile differentiates itself through its Un-carrier initiatives that eliminated industry pain points like contracts and overage fees, aggressive 5G network expansion, unlimited data plans, T-Mobile Tuesdays rewards program, and disruptive marketing that challenges traditional carrier practices.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.